Cyagen Biosciences
Cyagen provides mouse and rat models, cell line models, and stem cell reagents for scientific research.
Founded
2005Cyagen provides mouse and rat models, cell line models, and stem cell reagents for scientific research.
Founded with the mission to advance scientific research, Cyagen Biosciences specializes in generating knockout and transgenic mice, rats, and cell line models. The company also offers virus packaging, vector cloning, and stem cell and cell culture reagents. Cyagen aims to provide high-quality, reliable models and reagents to support researchers in the biomedical field, focusing on facilitating breakthroughs in genetics, disease research, and drug development.
Notable affiliated people include experienced scientists and industry experts who contribute to Cyagen's innovative solutions. The company has garnered investment from key players in the biotech sector, enhancing its research capabilities and market reach. Cyagen's achievements include developing a wide array of custom animal models and reagents that have significantly impacted scientific research globally. Their contributions have accelerated advancements in genetic research and therapeutic development, solidifying their reputation as a trusted partner in the scientific community.
Companies similar to Cyagen Biosciences include Transposagen Biopharmaceuticals, Kerafast, Alpha Genesis and CasTag Biosciences.
Cyagen Biosciences was founded in 2005.
Cyagen Biosciences' headquarters is located in Santa Clara, CA, US.
Cyagen Biosciences' most recent funding round was for $41M (USD) in February 2020.
As of Feb 26, 2020, Cyagen Biosciences has disclosed funding of $41M (USD). Undisclosed round amounts are excluded.
Cyagen Biosciences has 9 employees as of Feb 4, 2024.
CasTag Biosciences
